» Articles » PMID: 25569348

Protein Arginine Methyltransferase 6 Enhances Polyglutamine-expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy

Abstract

Polyglutamine expansion in androgen receptor (AR) is responsible for spinobulbar muscular atrophy (SBMA) that leads to selective loss of lower motor neurons. Using SBMA as a model, we explored the relationship between protein structure/function and neurodegeneration in polyglutamine diseases. We show here that protein arginine methyltransferase 6 (PRMT6) is a specific co-activator of normal and mutant AR and that the interaction of PRMT6 with AR is significantly enhanced in the AR mutant. AR and PRMT6 interaction occurs through the PRMT6 steroid receptor interaction motif, LXXLL, and the AR activating function 2 surface. AR transactivation requires PRMT6 catalytic activity and involves methylation of arginine residues at Akt consensus site motifs, which is mutually exclusive with serine phosphorylation by Akt. The enhanced interaction of PRMT6 and mutant AR leads to neurodegeneration in cell and fly models of SBMA. These findings demonstrate a direct role of arginine methylation in polyglutamine disease pathogenesis.

Citing Articles

ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complex.

Heller V, Wang L, Schneider E, Gerstner M, Bajer L, Decker R J Biol Chem. 2024; 301(2):108119.

PMID: 39716491 PMC: 11847539. DOI: 10.1016/j.jbc.2024.108119.


PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis.

Chu W, Peng W, Lu Y, Liu Y, Li Q, Wang H Adv Sci (Weinh). 2024; 11(40):e2403177.

PMID: 39120025 PMC: 11516099. DOI: 10.1002/advs.202403177.


Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA.

Karliner J, Liu Y, Merry D Proc Natl Acad Sci U S A. 2024; 121(29):e2321408121.

PMID: 38976730 PMC: 11260106. DOI: 10.1073/pnas.2321408121.


Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III.

Lu M, Wang X, Sun N, Huang S, Yang L, Li D CNS Neurosci Ther. 2024; 30(4):e14718.

PMID: 38615366 PMC: 11016346. DOI: 10.1111/cns.14718.


Prmt6 represses the pro-adipogenic Ppar-gamma-C/ebp-alpha transcription factor loop.

Gerstner M, Heller V, Fechner J, Hermann B, Wang L, Lausen J Sci Rep. 2024; 14(1):6656.

PMID: 38509237 PMC: 10954715. DOI: 10.1038/s41598-024-57310-9.


References
1.
Fernandez-Funez P, de Gouyon B, She W, Luchak J, Martinez P, Turiegano E . Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000; 408(6808):101-6. DOI: 10.1038/35040584. View

2.
Phalke S, Mzoughi S, Bezzi M, Jennifer N, Mok W, Low D . p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res. 2012; 40(19):9534-42. PMC: 3479215. DOI: 10.1093/nar/gks858. View

3.
Frankel A, Yadav N, Lee J, Branscombe T, Clarke S, Bedford M . The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem. 2001; 277(5):3537-43. DOI: 10.1074/jbc.M108786200. View

4.
Dormann D, Madl T, Valori C, Bentmann E, Tahirovic S, Abou-Ajram C . Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012; 31(22):4258-75. PMC: 3501225. DOI: 10.1038/emboj.2012.261. View

5.
Scaramuzzino C, Monaghan J, Milioto C, Lanson Jr N, Maltare A, Aggarwal T . Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo. PLoS One. 2013; 8(4):e61576. PMC: 3631215. DOI: 10.1371/journal.pone.0061576. View